IRIS
DELLA PORTA, MATTEO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.052
AS - Asia 4.362
EU - Europa 1.230
SA - Sud America 668
AF - Africa 221
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.892
SG - Singapore 2.707
CN - Cina 773
BR - Brasile 550
VN - Vietnam 377
FI - Finlandia 282
IE - Irlanda 202
NG - Nigeria 160
HK - Hong Kong 131
IT - Italia 129
DE - Germania 117
FR - Francia 114
CA - Canada 98
GB - Regno Unito 90
IN - India 84
NL - Olanda 73
SE - Svezia 56
JP - Giappone 47
TR - Turchia 43
MX - Messico 41
AR - Argentina 37
IQ - Iraq 33
ES - Italia 29
BD - Bangladesh 28
PL - Polonia 25
ZA - Sudafrica 22
RU - Federazione Russa 21
BE - Belgio 19
CL - Cile 16
PK - Pakistan 16
EC - Ecuador 15
UA - Ucraina 14
VE - Venezuela 14
SA - Arabia Saudita 13
PY - Paraguay 12
UZ - Uzbekistan 12
AU - Australia 11
ID - Indonesia 11
JO - Giordania 11
PH - Filippine 11
CO - Colombia 10
IR - Iran 10
KE - Kenya 8
KR - Corea 8
AT - Austria 7
CH - Svizzera 7
PE - Perù 7
CZ - Repubblica Ceca 6
MA - Marocco 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
JM - Giamaica 5
KZ - Kazakistan 5
LT - Lituania 5
TH - Thailandia 5
TN - Tunisia 5
EG - Egitto 4
IL - Israele 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
AL - Albania 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
NO - Norvegia 3
PA - Panama 3
RO - Romania 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EU - Europa 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MR - Mauritania 2
NI - Nicaragua 2
PT - Portogallo 2
SN - Senegal 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
Totale 13.540
Salva come PNG Salva come JPEG
Città #
Singapore 1.322
Wilmington 1.026
Chandler 954
Ashburn 440
The Dalles 411
Shanghai 369
San Mateo 356
Helsinki 282
San Jose 274
Ann Arbor 246
Dallas 207
Dublin 201
Boardman 186
Leawood 165
Beijing 161
Benin City 159
Lawrence 159
Princeton 159
Woodbridge 121
New York 119
Hong Kong 117
Ho Chi Minh City 116
Fairfield 101
Hanoi 101
Paris 93
Amsterdam 65
São Paulo 58
Los Angeles 46
Houston 45
Toronto 44
Tokyo 40
Milan 38
Seattle 38
London 35
Santa Clara 31
Council Bluffs 26
Haiphong 24
Cambridge 23
Falls Church 23
Norwalk 23
Orem 23
Montreal 20
Warsaw 20
Brussels 19
San Diego 19
Boston 18
Kocaeli 18
San Francisco 18
Columbus 17
Redwood City 17
Da Nang 16
Monmouth Junction 15
Rio de Janeiro 15
Belo Horizonte 14
Chennai 14
Phoenix 14
Stockholm 14
Brooklyn 13
Falkenstein 12
Nanjing 11
Redmond 11
Tashkent 11
Baghdad 10
Brasília 10
Curitiba 10
Hillsboro 10
Pune 10
Amman 9
Frankfurt am Main 9
Johannesburg 9
Mexico City 9
Mumbai 9
Tappahannock 9
Assago 8
Charlotte 8
Guangzhou 8
Manchester 8
Naples 8
New Delhi 8
Phủ Lý 8
Atlanta 7
Chicago 7
Guarulhos 7
Ankara 6
Biên Hòa 6
Des Moines 6
Hangzhou 6
Istanbul 6
Nairobi 6
Quito 6
São José do Rio Preto 6
Vancouver 6
Abbiategrasso 5
Bắc Ninh 5
Bến Tre 5
Campinas 5
Chengdu 5
Dhaka 5
Genoa 5
Guayaquil 5
Totale 9.028
Salva come PNG Salva come JPEG
Nome #
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts 206
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nat Commun. 2015 Jan 9;6:5901. 135
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group 116
Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia. 113
Costimulatory molecules and immune checkpoints are differentially expressed on different subsets of dendritic cells 113
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 113
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. 110
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signature 108
Clinical Effects of Driver Somatic mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With allogeneic Hematopoietic Stem-Cell Transplantation 104
CD34 and CD2 expression in acute promyelocytic leukemia. 100
Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes 100
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders. Cancer. 2006 Nov 1;107(9):2206-11. PubMed PMID: 16998940. 95
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 95
A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data. 94
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML 94
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. 92
Multicenter validation of a simplified method for paroxysmal nocturnal hemoglobinuria screening. 91
Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes. 88
Leukemic transformation of polycythemia vera: a single center study of 23 patients 87
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience. 87
Should cytoreductive treatment be performed before transplantation in patients with high-risk myelodysplastic syndrome? 86
Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears. 86
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised international prognostic scoring system (IPSS-R) 86
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes 86
Classification and prognostic evaluation of myelodysplastic syndromes 85
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes 85
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 84
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) 84
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival 83
Prognosis of secondary acute myeloid leukemia 82
Multicentre validation of a reproducible flow cytometric score for the diagnosis of low-risk myelodysplastic syndromes: results of a European LeukemiaNET study. 82
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications. 82
Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL). 82
Dendritic cells in acute promyelocytic leukaemia. 81
Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome. 81
Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors. 81
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. 81
ANALYSIS OF THE MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 81
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 81
Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients. 80
An unusual clinical presentation of multiple myeloma with involvement of the oro-pharynx. 80
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 80
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. 80
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. 79
Importance of classical morphology in the diagnosis of myelodysplastic syndrome. 78
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders 78
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) 77
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes 77
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 77
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 77
Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. 77
Burkitt-like lymphoma infiltrating a hyperfunctioning thyroid adenoma and presenting as a hot nodule. 76
THE IMPACT OF THE DEGREE OF ANEMIA ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME. A BASIS FOR PROGNOSTIC ASSESSMENT AND CLINICAL DECISION MAKING 76
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools. 76
Differentiation of follicular dendritic sarcoma cells into functional myeloid-dendritic cell-like elements. 76
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 76
Clinical and biological implications of driver mutations in myelodysplastic syndromes 75
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 75
Alterata espressione dei canali del Ca2+ in cellule progenitrici endoteliali di pazienti affetti da carcinoma cellulare renale, mielofibrosi idiopatica e tumore della mammella 75
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet 75
Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. 75
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome 75
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 75
Myelodysplastic syndromes and bone marrow microenvironment. 75
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 75
Hematologic responses with deferasirox therapy in transfusion-dependent myelodysplastic syndromes patients. 75
Simian virus 40 and lymphoproliferative disorder. 75
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. 74
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 74
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study 73
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome 73
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation 73
Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia 72
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 71
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. 71
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 70
Prognostic models in myelodysplastic syndromes 70
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow samples. 70
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. 70
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. 70
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis 70
High resolution melting for the identification of mutations in the iron responsive element of the ferritin light chain gene. 69
Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis. 69
Novel trial designs for high-risk myelodysplastic syndromes. 69
Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells. 69
Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes. 69
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. 69
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. 69
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients 69
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 69
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome 69
Second primary malignancies in ruxolitinib-treated myelofibrosis: Real-world evidence from 219 consecutive patients 68
Circulating endothelial cell separation from peripheral blood of patients affected by myelodysplastic syndromes: Preliminary results obtained by a new immunomagnetic procedure 68
VASCULAR ENDOTHELIAL GROWTH FACTOR OVEREXPRESSION IN BONE MARROW CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME: BIOLOGICAL AND CLINICAL RELEVANCE 68
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group. 68
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 68
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. 68
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. 68
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. 67
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 67
Totale 8.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021398 0 0 0 0 0 0 0 0 0 220 16 162
2021/20221.059 70 12 24 213 23 26 29 132 105 70 323 32
2022/20232.634 374 85 210 325 252 237 5 234 493 210 176 33
2023/20241.356 121 178 278 47 27 115 57 149 20 46 167 151
2024/20252.000 58 51 24 42 22 275 77 238 255 511 234 213
2025/20264.794 880 275 253 433 179 212 1.706 309 289 258 0 0
Totale 13.683